arrow
M

Mariaelena Capone

irccs aou san martino ist
H指数:31
被引数:4,323

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy

液体活检中的代谢组学特征与接受免疫检查点抑制剂治疗的转移性黑色素瘤患者的总生存期相关

2025-04-100
OA
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after de fi nitive surgery: a multicenter, retrospective cohort study (vol 65, 102290, 2023)

Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤术后的辅助治疗: 一项多中心,回顾性队列研究 (第65卷,102290,2023)

2024-05-010
OAAI
Upregulated expression of miR-4443 and miR-4488 in drug resistant melanomas promotes migratory and invasive phenotypes through downregulation of intermediate filament nestin
2023-11-274
OAAI
Dabrafenib plus trametinib versus anti-PD-1 monotherapy as adjuvant therapy in BRAF V600-mutant stage III melanoma after definitive surgery: a multicenter, retrospective cohort study

Dabrafenib联合曲美替尼与anti-PD-1单药治疗BRAF V600-mutant III期黑色素瘤确定性手术后的辅助治疗: 一项多中心,回顾性队列研究

2023-11-017
OAAI
Germline immunomodulatory expression quantitative trait loci (ieQTLs) associated with immune-related toxicity from checkpoint inhibition

种系免疫调节表达与检查点抑制引起的免疫相关毒性相关的数量性状基因座 (ieqtl)

2023-08-014
OA
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
2023-02-239
OAAI
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study

高危、可切除BRAF突变和野生型黑色素瘤患者的新辅助治疗联合辅助治疗或序贯vemurafenib、cobimetinib和阿特珠单抗: neo-tim,一项II期随机非对比研究

2023-02-091
OAAI
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors

免疫特征预测免疫检查点抑制剂治疗的癌症患者自身免疫毒性的发展

MED
IF11.8
2023-02-0148
OA
Targeting the MITF/APAF-1 axis as salvage therapy for MAPK inhibitors in resistant melanoma
2022-11-017
OA
Altered Frequencies and Functions of Innate Lymphoid Cells in Melanoma Patients Are Modulated by Immune Checkpoints Inhibitors

免疫检查点抑制剂调节黑色素瘤患者先天淋巴样细胞的频率和功能改变

2022-01-3110
OAAI